AGBT

Researchers for the InPSYght project are sequencing 10,000 genomes and generating linked-read data for 500 to better understand schizophrenia and bipolar disorder. 

Researchers highlighted the successes and challenges of targeted and comprehensive cancer sequencing at two recent conferences.

NanoString said its sequencing technology harnesses its expertise in optical barcodes and that it would develop it for clinical use to complement its existing products.

Researchers described using long-read sequencing technology to develop diagnostic assays, sequence through complex gene fusions, and in virology applications.

Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.

Collaborators will sequence 100,000 Asian genomes from various disease cohorts and generate 50 to 100 Asian-specific reference genomes. 

The Broad Institute is running Chromium in its lab, while other early-access users are collaborating with 10X Genomics on single-cell RNA-seq and exome studies.

Foundation Medicine plans to publish a validation study of its 61-gene liquid biopsy test in a journal and launch the test by the end of the quarter.